The Global Digital Sphygmomanometer Market size is expected to reach $1.3 billion by 2028, rising at a market growth of 4.9% CAGR during the forecast period.
A digital sphygmomanometer, also known as a blood pressure monitor or blood pressure gauge, is a device that is used to monitor blood pressure. The digital sphygmomanometer consists of an inflatable cuff to collapse and releases the artery in controlled manner. A digital sphygmomanometer has an inflatable cuff, a measuring unit, and a mechanism of inflation. Also, it has a digital meter that consists of oscillometric measurement and an electronic calculation.
The inflation while measuring blood pressure with this device can be done by using manual or automatic inflation. Yet, both types of inflation are electronic and are easy to use despite any training and can be used anywhere. The digital sphygmomanometer measures systolic and diastolic pressure with the help of oscillometric detection, which consists of either deformable membranes or differential piezoresistance. The digital sphygmomanometer measures the average blood pressure and pulse rate.
The measuring of systolic and diastolic pressure is more inaccurate than a manual meter. Some patients are suggested not to use digital sphygmomanometer especially those, with arteriosclerosis, arrhythmia, preeclampsia, pulsus alternans, and pulsus paradoxus as the calculation with digital oscillometric may not be correct with these conditions. The digital sphygmomanometer use a cuff placed as to provide accurate results, inverse order or profitability and convenience to the wrist and upper arm.
The oscillometric detection provides readings of the blood pressure different from the auscultation. The main advantage of using a digital sphygmomanometer is the comfort that it provides while operating. Digital sphygmomanometers are perfect for home monitoring of patients, especially when someone is measuring blood pressure by themselves.
The market for digital sphygmomanometers has been positively affected by the outspread of COVID-19. This is due to the increased adoption of digital sphygmomanometers for measuring blood pressure at home during the pandemic period. A wide population base has been advised to regularly measure the blood pressure, especially those with the long-term hypertension. This was to make sure that they may not get infected and also to reduce the risk of cross infections they may spread to healthcare workers measuring the blood pressure.
Over the previous few years, telehealth usage has increased. Patients quickly realized that there were additional advantages to telemedicine, despite the fact that the Covid-19 pandemic was the reason for the move from regular clinic visits to virtual ones. Telemedicine can deliver precise and prompt healthcare suggestions that were previously sought from a doctor. With this rising adoption of telehealth, the need for at home monitoring for health data such as blood pressure has become crucial.
The prevalence of hypertension has increased across the globe. The risk of developing heart, brain, kidney, and other disorders is dramatically increased by hypertension, often known as raised blood pressure. According to WHO; worldwide, 1.28 billion persons between the ages of 30 and 79 are projected to have hypertension, with the majority (two-thirds) residing in low- and middle-income nations. Adults with hypertension are reportedly 46% less likely to be aware of their condition.
One of the main issues impeding the growth of the digital sphygmomanometer market is the huge competition among suppliers and the prevalence of counterfeit goods. Due to the presence of numerous new and small businesses together with well-established vendors, the market has become very competitive. The majority of the digital sphygmomanometer are similar in design and technology and are available from both international and local providers. To increase their profit margins, multinational corporations make enormous investments in marketing, promotion, and brand-quality enhancement.
On the basis of type, the digital sphygmomanometer market is segmented into arm type and wrist type. In 2021, the wrist type segment garnered a substantial revenue share in digital sphygmomanometer market. Wrist digital sphygmomanometer is excellent for individuals with very large arms who do not have access to an arm cuff that fits properly. If so, wrist blood pressure measurement can be beneficial.
Based on end user, the digital sphygmomanometer market is classified into hospitals & clinics, home care settings and others. In 2021, the hospitals & clinics segment held the highest revenue share in the digital sphygmomanometer market. The presence of vast numbers of patients in hospitals and clinics is estimated to support the market’s expansion in this segment.
| Report Attribute | Details |
|---|---|
| Market size value in 2021 | USD 915.2 Million |
| Market size forecast in 2028 | USD 1.3 Billion |
| Base Year | 2021 |
| Historical Period | 2018 to 2020 |
| Forecast Period | 2022 to 2028 |
| Revenue Growth Rate | CAGR of 4.9% from 2022 to 2028 |
| Number of Pages | 149 |
| Number of Tables | 250 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Type, End User, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Region wise, the digital sphygmomanometer market is analyzed across North America, Europe, Asia pacific, and LAMEA. In 2021, the North America region witnessed the largest revenue share in the digital sphygmomanometer market. The rise in the adoption of digital sphygmomanometers by clinicians and patients, increasing number of patients with hypertension, and development in the healthcare sector are the factors propelling the growth of the digital sphygmomanometer market. In addition, the market is witnessing significant growth in the region due to high affordability of patients willing to invest in such devices.
Free Valuable Insights: Global Digital Sphygmomanometer Market size to reach USD 1.3 Billion by 2028
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Omron Corporation, Panasonic Holdings Corporation, Halma PLC, Baxter International, Inc., A&D HOLON Holdings Company, Limited, Contec Medical Systems Co., Ltd., Microlife AG (Midas Company Limited), Rossmax International Ltd., American Diagnostics Corporation and Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd
By Type
By End User
By Geography
The global Digital Sphygmomanometer Market size is expected to reach $1.3 billion by 2028.
Rising need of home blood pressure monitoring are driving the market in coming years, however, Growing competition in the market restraints the growth of the market.
Omron Corporation, Panasonic Holdings Corporation, Halma PLC, Baxter International, Inc., A&D HOLON Holdings Company, Limited, Contec Medical Systems Co., Ltd., Microlife AG (Midas Company Limited), Rossmax International Ltd., American Diagnostics Corporation and Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd
The expected CAGR of the Digital Sphygmomanometer Market is 4.9% from 2022 to 2028.
The Arm Type market is leading the segment in the Global Digital Sphygmomanometer Market by Type in 2021; thereby, achieving a market value of $889.3 million by 2028.
The North America market dominated the Global Digital Sphygmomanometer Market by Region in 2021; thereby, achieving a market value of $457.1 million by 2028.
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
